mortality/aging
nervous system
• brain cellularity is reduced particularly in the cortex and thalamus
• the cerebellum and nuclei of the pons and medulla exhibit lose of cellularity that is associated with abundant pyknotic cells
• apoptotic cells are observed in the thalamus, dendate gyrus of the hippocampus and cerebellum
|
• large neurons are surrounded by ameboid-shaped cells (microglia-like) and those in the motor trigeminal nuclei and pons regions have huge vacuoles likely due to lipid accumulation
|
• neurons in the CA3 and dendate gyrus undergo degeneration
• however, neurons in the CA1 are unaffected
|
• pyramidal neurons are lost from the cortical layer
|
• the number of Purkinje cells in the cerebellum is decreased compared to in wild-type mice and those present exhibit a profound swelling in their axons
|
behavior/neurological
• mice develop a rapidly progressing neurological disease beginning at day 10 with abnormal gait, hyperextension of the neck and seizure
|
hematopoietic system
• visceral Gaucher cells (macrophages with lipid accumulation observed in Gaucher disease) are present in the spleen and liver
|
homeostasis/metabolism
• glucosylceramide accumulates in the brain, spleen and liver unlike in wild-type mice
|
immune system
• visceral Gaucher cells (macrophages with lipid accumulation observed in Gaucher disease) are present in the spleen and liver
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
Gaucher's disease type II | DOID:0110958 |
OMIM:230900 |
J:127108 |